NVAX Stock Outruns Moderna As Vaxcyte’s Shot Clears A Late-Stage Test

5 articles · 4 sources · updated 18 days ago

Recent

Asianet NewsableNVAX Stock Outruns Moderna As Vaxcyte’s Shot Clears A Late-Stage Test18 days ago · By Stocktwits Inc

0

pharmaphorumVaxcyte's pneumococcal jab exceeds expectations18 days ago · By Phil.Taylor

0

STATSTAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and more19 days ago · By Ed Silverman

0

STATSTAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market19 days ago · By Jason Mast

0

MedscapeVaxcyte Shares Surge as Pneumococcal Vaccine Succeeds in Late-stage Trial19 days ago

0